Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc drugs

2 results
  • benefix

    (Coagulation Factor Ix (Recombinant))
    Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc
    BeneFIX treats hemophilia B (congenital factor IX deficiency) in adults and children. Indicated for on-demand treatment and control of bleeding, perioperative bleeding management, and routine prophylaxis to reduce bleeding episodes. Not indicated for immune tolerance induction.
  • xyntha

    (Antihemophilic Factor (Recombinant))
    Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc
    Xyntha is indicated for adults and children with hemophilia A (congenital factor VIII deficiency) for on-demand treatment and control of bleeding episodes, perioperative management, and routine prophylaxis to reduce bleeding frequency. Not indicated for von Willebrand's disease.